The Scientist

» clinical trials and neuroscience

Most Recent

image: Characterizing Sleep

Characterizing Sleep

By and | March 1, 2016

Sleep-like patterns of neural activity are apparent not just at the level of the whole brain, but also in isolated neural circuits.

0 Comments

image: Go To Bed!

Go To Bed!

By | March 1, 2016

The immediate consequences of losing out on sleep may be harbingers of long-term repercussions.

0 Comments

image: Sleep’s Kernel

Sleep’s Kernel

By and | March 1, 2016

Surprisingly small sections of brain, and even neuronal and glial networks in a dish, display many electrical indicators of sleep.

1 Comment

image: Cautious Optimism About ZMapp Trial

Cautious Optimism About ZMapp Trial

By | February 25, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Opinion: Why Most TBI Studies Fail

Opinion: Why Most TBI Studies Fail

By | February 24, 2016

Thoughts on how to redesign clinical trials for traumatic brain injury

1 Comment

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Demystifying BOLD fMRI Data

Demystifying BOLD fMRI Data

By | February 17, 2016

What does blood oxygen level–dependent functional magnetic resonance imaging actually tell us about brain activity? 

0 Comments

image: More Mini Brains

More Mini Brains

By | February 17, 2016

Simple versions of brain organoids could serve as new models for testing the effects of drugs, researchers reported at this year’s AAAS meeting. 

0 Comments

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

image: Hormone Hangover

Hormone Hangover

By | February 1, 2016

Medication to prevent prematurity in humans harms cognitive flexibility in rats.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech